ahlam1399
10-01-2016, 11:11 AM
J&J psoriasis drug tops placebo, Humira in late stage study
Oct 1 (Reuters) - An experimental biotech drug developed byJohnson & Johnson proved more effective at clearingmoderate to severe cases of the skin condition plaque psoriasisthan a placebo or Abbvie Inc's big-selling Humira,according to data from a late stage study presented on Saturday.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=o7TpoAJLdLw:750gUr7AkiM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=o7TpoAJLdLw:750gUr7AkiM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=o7TpoAJLdLw:750gUr7AkiM:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=o7TpoAJLdLw:750gUr7AkiM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=o7TpoAJLdLw:750gUr7AkiM:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/o7TpoAJLdLw
Oct 1 (Reuters) - An experimental biotech drug developed byJohnson & Johnson proved more effective at clearingmoderate to severe cases of the skin condition plaque psoriasisthan a placebo or Abbvie Inc's big-selling Humira,according to data from a late stage study presented on Saturday.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=o7TpoAJLdLw:750gUr7AkiM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=o7TpoAJLdLw:750gUr7AkiM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=o7TpoAJLdLw:750gUr7AkiM:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=o7TpoAJLdLw:750gUr7AkiM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=o7TpoAJLdLw:750gUr7AkiM:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/o7TpoAJLdLw